| Product Code: ETC9963329 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United States (US) Continuous Subcutaneous Insulin Infusion Market Overview |
3.1 United States (US) Country Macro Economic Indicators |
3.2 United States (US) Continuous Subcutaneous Insulin Infusion Market Revenues & Volume, 2021 & 2031F |
3.3 United States (US) Continuous Subcutaneous Insulin Infusion Market - Industry Life Cycle |
3.4 United States (US) Continuous Subcutaneous Insulin Infusion Market - Porter's Five Forces |
3.5 United States (US) Continuous Subcutaneous Insulin Infusion Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.6 United States (US) Continuous Subcutaneous Insulin Infusion Market Revenues & Volume Share, By End Use, 2021 & 2031F |
3.7 United States (US) Continuous Subcutaneous Insulin Infusion Market Revenues & Volume Share, By Patient Type, 2021 & 2031F |
4 United States (US) Continuous Subcutaneous Insulin Infusion Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of diabetes in the United States |
4.2.2 Growing awareness about the benefits of continuous subcutaneous insulin infusion therapy |
4.2.3 Technological advancements in insulin pump devices |
4.2.4 Favorable reimbursement policies for diabetes management |
4.2.5 Preference for non-invasive insulin delivery methods |
4.3 Market Restraints |
4.3.1 High cost associated with continuous subcutaneous insulin infusion therapy |
4.3.2 Limited accessibility to advanced insulin pump technologies in certain regions |
4.3.3 Concerns regarding the accuracy and reliability of insulin pump devices |
4.3.4 Regulatory challenges and stringent approval processes for new devices |
4.3.5 Competition from alternative diabetes management solutions |
5 United States (US) Continuous Subcutaneous Insulin Infusion Market Trends |
6 United States (US) Continuous Subcutaneous Insulin Infusion Market, By Types |
6.1 United States (US) Continuous Subcutaneous Insulin Infusion Market, By Product Type |
6.1.1 Overview and Analysis |
6.1.2 United States (US) Continuous Subcutaneous Insulin Infusion Market Revenues & Volume, By Product Type, 2021- 2031F |
6.1.3 United States (US) Continuous Subcutaneous Insulin Infusion Market Revenues & Volume, By Tethered, 2021- 2031F |
6.1.4 United States (US) Continuous Subcutaneous Insulin Infusion Market Revenues & Volume, By Patch, 2021- 2031F |
6.2 United States (US) Continuous Subcutaneous Insulin Infusion Market, By End Use |
6.2.1 Overview and Analysis |
6.2.2 United States (US) Continuous Subcutaneous Insulin Infusion Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.2.3 United States (US) Continuous Subcutaneous Insulin Infusion Market Revenues & Volume, By Homecare, 2021- 2031F |
6.2.4 United States (US) Continuous Subcutaneous Insulin Infusion Market Revenues & Volume, By Laboratories, 2021- 2031F |
6.3 United States (US) Continuous Subcutaneous Insulin Infusion Market, By Patient Type |
6.3.1 Overview and Analysis |
6.3.2 United States (US) Continuous Subcutaneous Insulin Infusion Market Revenues & Volume, By Type 1 diabetes, 2021- 2031F |
6.3.3 United States (US) Continuous Subcutaneous Insulin Infusion Market Revenues & Volume, By Type 2 diabetes, 2021- 2031F |
7 United States (US) Continuous Subcutaneous Insulin Infusion Market Import-Export Trade Statistics |
7.1 United States (US) Continuous Subcutaneous Insulin Infusion Market Export to Major Countries |
7.2 United States (US) Continuous Subcutaneous Insulin Infusion Market Imports from Major Countries |
8 United States (US) Continuous Subcutaneous Insulin Infusion Market Key Performance Indicators |
8.1 Patient adherence rate to continuous subcutaneous insulin infusion therapy |
8.2 Rate of adoption of insulin pump therapy among diabetes patients |
8.3 Average time taken for insulin pump manufacturers to bring new products to market |
8.4 Number of clinical trials and studies supporting the efficacy of continuous subcutaneous insulin infusion therapy |
8.5 Percentage of healthcare providers recommending insulin pump therapy to their patients |
9 United States (US) Continuous Subcutaneous Insulin Infusion Market - Opportunity Assessment |
9.1 United States (US) Continuous Subcutaneous Insulin Infusion Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.2 United States (US) Continuous Subcutaneous Insulin Infusion Market Opportunity Assessment, By End Use, 2021 & 2031F |
9.3 United States (US) Continuous Subcutaneous Insulin Infusion Market Opportunity Assessment, By Patient Type, 2021 & 2031F |
10 United States (US) Continuous Subcutaneous Insulin Infusion Market - Competitive Landscape |
10.1 United States (US) Continuous Subcutaneous Insulin Infusion Market Revenue Share, By Companies, 2024 |
10.2 United States (US) Continuous Subcutaneous Insulin Infusion Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here